Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MAOA | P21397 | 2/20 | 0.56 |
| ▸ | MAOB | P27338 | 5/20 | 0.55 |
| ▸ | MMP2 | P08253 | 1/20 | 0.54 |
| ▸ | MMP9 | P14780 | 1/20 | 0.54 |
| ▸ | ADAM17 | P78536 | 1/20 | 0.54 |
| ▸ | HPGD | P15428 | 3/20 | 0.53 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.53 |
| ▸ | TYR | P14679 | 1/20 | 0.53 |
| ▸ | DAO | P14920 | 1/20 | 0.53 |
| ▸ | AKR1B1 | P15121 | 1/20 | 0.53 |
| ▸ | POLB | P06746 | 1/20 | 0.53 |
| ▸ | RAB9A | P51151 | 4/20 | 0.51 |
| ▸ | NPC1 | O15118 | 3/20 | 0.51 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.51 |
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.50 |
| ▸ | KDM4E | B2RXH2 | 3/20 | 0.50 |
| ▸ | LGALS3 | P17931 | 2/20 | 0.49 |
| ▸ | LGALS9 | O00182 | 1/20 | 0.49 |
| ▸ | LGALS8 | O00214 | 1/20 | 0.49 |
| ▸ | LGALS2 | P05162 | 1/20 | 0.49 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1284769 | 0.90 | MAOB (0.57) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL1285122 | 0.86 | MAOB (0.56) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL24486866 | 0.85 | MMP2 (0.48) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL1284886 | 0.85 | MAOB (0.56) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL13612673 | 0.83 | MAOA (0.61) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL27625488 | 0.83 | MMP2 (0.67) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL15455155 | 0.83 | MMP2 (0.52) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL24486792 | 0.83 | MMP2 (0.46) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL1284616 | 0.82 | MAOB (0.52) | MAOAMAOBMMP2MMP9ADAM17 | |
| SCHEMBL22821274 | 0.82 | MAOB (0.52) | MAOAMAOBMMP2MMP9ADAM17 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7615332-B2 | Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process | CANON KABUSHIKI KAISHA (JP) | 2009-11-10 | — | — | US | disclosed |
| US-20090233232-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | CANON KABUSHIKI KAISHA (JP) | 2009-09-17 | — | — | US | disclosed |
| EP-1956430-A1 | Photosensitive compound, photosensitive composition, resist pattern forming method, and device production process | Canon Kabushiki Kaisha (JP) | 2008-08-13 | — | — | EP | disclosed |
| US-20080187864-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | CANON KABUSHIKI KAISHA (JP) | 2008-08-07 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090233232-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | FRG1, PAH, RER1 | MAOA 1322/4885MAOB 1047/4885MMP2 4734/4885 |
| US-20080187864-A1 | PHOTOSENSITIVE COMPOUND, PHOTOSENSITIVE COMPOSITION, RESIST PATTERN FORMING METHOD, AND DEVICE PRODUCTION PROCESS | FRG1, PAH, RER1 | MAOA 1322/4885MAOB 1047/4885MMP2 4734/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.